Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Vetro C 

PROVIDER: S-EPMC12554896 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature